Promoting open talks about sexual health after gynecologic cancer
Official title: Promoting Effective Clinical Communication about Sexual Health after Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention
Funded at Research Inst of Fox Chase Can Ctr · NIH-11379117 · Data updated 2026-11-12
A patient-focused program helps women with gynecologic cancer start and guide conversations about sexual health with their doctors.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst of Fox Chase Can Ctr NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2026 |
| Award (this year) | $1,579,288 |
| NIH project number | 4R01CA285674-03 |
| Project ID | NIH-11379117 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women treated for gynecologic cancer who have sexual health concerns and are able to participate in a randomized trial.
✕Less likely to help
Patients without interest in discussing sexual health or who are unable to participate in a trial may not benefit.
What this research studies
This project tests a patient-centered intervention, STC-GC, designed to help women with gynecologic cancer bring up sexual health concerns during clinic visits. Building on a breast cancer version, the program was adapted to address the unique needs and treatments of GC patients and shown to be feasible in a pilot. In a randomized trial with 200 participants, researchers will measure how well the intervention improves patients’ ability to initiate and steer discussions about sexual health with their clinicians. If effective, the approach could empower patients to get better support and information for aftercare and quality of life.
Why it matters
Potential benefit: If successful, the intervention could help GC patients communicate more effectively about sexual health, leading to better symptom management and quality of life.
How similar studies have gone: Preliminary work in breast cancer showed feasibility and acceptability, with promising signals for improving patient-clinician communication; GC-specific effectiveness is being tested.
Where this research is happening
-
Research Inst of Fox Chase Can Ctr
Philadelphia, United States Active
Researchers
- Principal investigator: Reese, Jennifer Barsky — Research Inst of Fox Chase Can Ctr
- Study coordinator: Reese, Jennifer Barsky
Related research
Other NIH-funded projects on the same topics.
-
Improving Conversations About Sexual Health After Gynecologic Cancer
This project helps women who have had gynecologic cancer feel more confident and prepared to talk with their doctors about sexual health concerns.
-
Improving communication about sexual health for women after gynecologic cancer treatment
This study is designed to help women who have been treated for gynecologic cancer talk more openly about their sexual health with their doctors, using a special program called Starting the Conversation – Gynecologic Cancer, to make these important discussions easier and less stressful.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
-
Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia
This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.
-
Shorter antifungal treatment for kids with candidemia
A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.